[{"Assets_0_Q1_USD":163399000.0,"CommonStockSharesOutstanding_0_Q1_shares":60844300.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-26557000.0,"NetIncomeLoss_1_Q1_USD":-23317000.0,"StockholdersEquity_0_Q1_USD":145982000.0,"Ticker":"MYOV","CIK":"1679082","name":"MYOVANT SCIENCES LTD.","OfficialName":"Myovant Sciences Ltd. Common Shares","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1001965304.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20170810"}]